YONDELIS (trabectedin) and HALAVEN (eribulin) are the first chemotherapies originally derived from marine life, although they are now synthetically made. Both drugs are approved for the treatment of liposarcoma, and Yondelis also for the treatment of leiomyosarcoma.
Following a lung cancer diagnosis, staging determines the best options for treatment. Many factors are evaluated, including the size of the tumor and the extent of spread.